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Abstract:  
 
Objectives: 
Door-Needle-times (DNT) of 20 minutes are feasible when Computer Tomography (CT) is used for 
first-line brain-imaging to assess stroke-patients’ eligibility for intravenous-tissue-Plasminogen-
Activator (iv-tPA), but the more time-consuming Magnetic Resonance Imaging (MRI)-based-
evaluation is superior in detecting acute ischaemia.  
The aim of this study was to compare DNT for CT versus MRI-based acute stroke-evaluation.  
 
Patients and Methods: 
Consecutive acute stroke-patients admitted to an acute stroke-unit were quasi-randomized to CT 
or MRI-based assessment and treated with iv-tPA, if eligible.  
Door-Decision-Time and DNT for CT versus MRI-examined patients were compared and predictors 
of treatment-delay identified.  
The effect of using MRI as the primary imaging-strategy upon the modified-Rankin-Scale (mRS) at 
three months was assessed using the validated electronic COMPASS-tool.  
 
Results: 
Four-hundred-forty-four patients were included. Median DNT in CT-allocated patients (22 (IQR 16) 
min) was significantly shorter than in MRI-allocated patients (30 (IQR 14) min), p=0.005. 
The COMPASS-tool predicted that chance of independent living (mRS<3) at 3 months decreased 
with 1% in 16.9% of iv-tPA-treated MRI-examined patients due to the median treatment-delay of 8 
minutes.  In MRI-allocated patients; MRI were not feasible in 23.7% due to contraindications, in 
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16.1% due to clinical conditions and in 6.8% due to organizational issues. 16.8% of CT-allocated 
patients (pregnant/<30 years) received MRI to avoid X-ray irradiation or due to doubtful clinical 
presentation of stroke requiring MRI confirmation prior to receiving tPA.  
 
Conclusions: 
CT-based acute stroke evaluation is significantly shorter more feasible than MRI-based evaluation 
and potentially translates into time-related superior long-term outcome. However, the clinical 
impact is not detectable.  
 
Introduction: 
The ideal primary radiological image-modality used for evaluation of patients with symptoms of 
acute stroke prior to administration of intravenous-tissue-Plasminogen-Activator (iv-tPA) must be: 
Of diagnostic quality, short duration to diminish treatment-delay, feasible in the majority of 
patients and suitable for examination of restless, claustrophobic or critically ill patients. The ability 
to safely exclude intracerebral hemorrhage and stroke-mimicking pathologies contraindicating iv-
tPA is further imperative. Demonstration of early signs of ischemia is not an indispensable 
requirement but is helpful in patients with atypical clinical presentations.   
The pros and cons of Computer-Tomography (CT) versus Magnetic-Resonance-Imaging (MRI) to 
evaluate patients with symptoms of acute stroke prior to intravenous-tissue-Plasminogen-
Activator (iv-tPA) treatment have been widely debated. CT-based Door-to-Needle-Times (DNT) of 
20 minutes have been proven feasible (1) motivated by time-dependent efficacy of iv-tPA, but the 
more time-consuming MRI-based evaluation may provide additional information about hyper-
acute cerebral ischemia (2) and iv-tPA-contraindicating stroke-mimicking pathology. 
 
To answer the question if CT or MRI is the optimal imaging-strategy in the evaluation of patients 
with symptoms of acute stroke, a single-center quasi-randomized clinical-trial was conducted to 
compare several aspects of CT and MRI-based acute stroke-evaluation prior to administration of 
iv-tPA.   
The aim of this preplanned sub-study was to compare DNT and perform a simulated prediction of 
the difference in long-term outcome between CT and MRI-examined patients. 
Patients and Methods:  
This quasi-randomized clinical-trial included all consecutive patients (>17 years of age) admitted 
with symptoms of acute stroke within 4.5 hours from symptom-onset to a single hyper-acute 
stroke-unit, on even weekdays from 8a.m. to 3p.m., from December 2013 to November 2015. All 
patients from the Region of Copenhagen (1.7 million) are referred directly to our institution on 
even dates and to another University-hospital on uneven dates.  
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In summary, all patients were by the emergency-service directly brought to a dedicated stroke-
room within the Department of Radiology and were then evaluated according to a fast-track set-
up. The patients were met by a pre-notified stroke-team; comprising a neurologist, a stroke-nurse, 
a neuro-radiologist, two radiographers and an orderly. The team members worked 
simultaneously, each with well-defined allocated tasks.  
The neurologist was a senior-stroke-neurological-consultant (n=6, seeing 74.5% of the patients), a 
certified neurologist (n=4, seeing 12.8% of the patients) or a neurological-resident in the final six 
month of training prior to full neurological certification under telephone-supervision of a senior-
stroke-neurological-consultant (n=14, seeing 12.6% of the patients).   
If eligible, patients were treated with iv-tPA and if appropriate with endovascular therapy after the 
allocated imaging had been performed.   
 
Randomization and imaging: 
All patients were quasi-randomized to receive CT or MRI according to an equal number of 
predefined CT and MRI-days that were stated in calendar posted in the Department of Radiology 
well in advance.  
 
In a quasi-randomized trial, patients are systematically allocated according to a predefined system (such as 
alternation, date of birth, case record number or as in our case according to admission date). 
All patients were systematically assessed according to a Standard-Operational-Plan (SOP) for 
undertaking CT and MR imaging. The SOP was strictly followed in accordance with allocation but 
allowed for predefined cross-over between the CT and MRI in case of contraindications or vital 
medical needs for MR or CT such as: suspicion of intracerebral malignancy; MRI incompatible 
implants; lack of reliable information about MRI contraindications; too large body size; severe 
illness or restlessness that MRI was not safe; pregnant; less than 30 years of age. MRI-safety was 
adhered to according to International Guidelines. 
 
On CT-days, a non-contrast-CT of cerebrum (scan-time 17.3 seconds) was conducted followed by a 
CT-angiography (scan-time 31.6 seconds) if no contraindications, preferably after administration of 
the iv-tPA-bolus.  
On MRI-days, patients had DWI, Flair and Gradient sequences (scan-time 6.4 minutes) followed by 
a Time of Flight-(TOF)-angiography (scan-time 7.0 minutes), preferably after administration of the 
iv-tPA-bolus.  
 
If the iv-tPA was administered before the angiography, the angiography was conducted 
immediately after administration of the tPA-bolus and thus no later than two minutes after the 
initiation of the tPA-therapy. The patient remained on the scanner bed throughout image 
conduction and administration of the tPA.  
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The neuro-radiologist planned the image-conduction in collaboration with the CT and MRI-
technicians when pre-notified of an incoming patient. No patients were allowed to wait for more 
than 10 minutes for the allocated imaging to be performed; if the radiological staff foresaw that 
the allocated image-modality would not be available in time, a cross-over was arranged to avoid 
treatment-delays in accordance with the SOP.   
 
The imaging was assessed by a neuro-radiologist who read the imaging directly in the control-
room before passing on the conclusion to the stroke-physician.  
On MRI-days three 20 minutes time-slots were reserved for the trial; when acute MRI-allocated 
stroke-patients arrived, the MRI-technicians were as a consequence able to catch-up on the 
preplanned MRI-examinations and thus fully exploit the MRI-capacity.  
Sample size:  
As no preceding equivalent trials have been conducted, sample-size was estimated based on an 
anticipated difference in DNT of MRI and CT-based assessment. With a least clinically relevant 
difference of 10 minutes, SD at 20 minutes, α-two-tailed at 0.05 and β at 90%, the total number of 
participants was estimated at 172 patients. The sample-size was extended in order to allow for 
secondary outcomes not reported in this sub-study. 
 
MRI-safety: 
On MRI-days, MRI-safety-procedures were strictly adhered to. To reduce the time taken to 
complete the safety-procedures an MRI-radiographer was present when the neurologist 
completed the MRI-safety-checklist rather than duplicating the procedure in the MRI-suite.  
Outside the MRI-room, a short time-out was imposed to ensure that the MRI-safety-checklist had 
been reviewed and loose metal-objects removed from both patient and staff-members entering 
the MRI-room.   
A pilot-period of two weeks preceded the trial to ensure high efficiency and staff-awareness in 
regard to the new time-saving MRI-safety-routines.  
Time-registration:  
To ensure a consistent time-registration, intervals from admission to treatment-decision (Door-
Decision-Time (DDT)) and to administration of the iv-tPA-bolus (DNT) were recorded 
systematically.  
Symptom-onset was defined as witnessed stroke-symptom-onset or when the patient was last 
seen well. Admission was defined as when the patient entered the dedicated stroke-room at 
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which point the stroke-nurse finalized the electronic patient-registration. Time from arrival of the 
ambulance to the patient entered the stroke-room was less than one minute.  
The time of the treatment-decision was defined as when the stroke-physician decided to prescribe 
or refrain from prescribing iv-tPA-treatment.  
Time of iv-tPA-administration is a mandatory part of the stroke-patient-file from which the time of 
iv-tPA-administration was later extracted.  
The number of patients evaluated during a shift (by the same stroke-physician) and 20-minute 
time-intervals between arrivals of patients were calculated. 
 
Outcomes: 
National Institute of Health Stroke Scale (NIHSS) and pre-onset modified Rankin Scale (pre-mRS) 
were on admission established by the stroke-physician.  
As part of the institutional follow-up, the iv-tPA-treated patients were by telephone contacted by 
an outpatient-nurse who recorded the mRS at three months.    
 
The COMPuterised decision Aid for Stroke thrombolysiS (COMPASS)-app (3, 4) is validated for 
prediction of the risk of iv-tPA-induced Symptomatic-Intracerebral-Hemorrhage (SICH) according 
to the SITS-MOST-definition, mortality, independent living (mRS <3) and dependent living (mRS 3-
5) at three months after iv-tPA treatment. The app gives the risk (in percent) of each of the four 
outcomes based on entering of the patient’s individual risk profile; age, gender, diabetes, previous 
stroke, presence of recent infarct on CT or MRI, daily use of aspirin/clopidogrel, time from onset to 
iv-tPA-treatment (ONT), glucose-concentration, systolic blood-pressure and NIHSS.  
We used the COMPASS-app to predict the four outcome-measures for each individual iv-tPA-
treated MRI-allocated patient in different two scenarios; 1, the actual scenario where the patient 
is admitted on an MRI-day (imitating admission to a primary MRI-based stroke center) 2, a 
theoretic scenario where the patient instead is admitted on a CT-day (imitating admission to a 
primarily CT-based stroke center). The two predictions were based on entering of the true 
individual ONT and the true ONT subtracted the median difference in ONT between MRI and CT-
allocated patients respectively (the treatment-delay caused by MRI compared to CT-based 
assessment). All other predictors remained fixed. The four outcomes where thus predicted twice 
for each patient; an individual prediction illustrating admission on an MRI versus a CT-day 
respectively. The predicted four paired outcomes were compared for each iv-tPA-treated MRI-
allocated patient.     
Statistical analysis: 
Continuous data were compared with students-t-test and non-parametric continuous data with 
Mann-Whitney-U-test. Categorical data were compared with Chi-square-tests. 
Two random-effects-models allowing for the cluster-effect of the stroke-physicians each seeing 
more than one patient were constructed to identify predictors of DDT and DNT, the latter only for 
iv-tPA-treated patients. The following variables were tested as predictors of DDT and DNT in both 
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models; age, gender, conducted image-modality, crossover from allocated scan, NIHSS, stroke-
physician-seniority, time to arrival of the next patient (20-minute intervals) and the numbers of 
patients evaluated during the shift by the same stroke-physician. Discharge-diagnosis (ischemic 
stroke, Intracerebral Hemorrhage, TIA or stroke-mimicking-diagnosis), pre-onset mRS, and if 
thrombolysis was prescribed were furthermore added to the model testing predictors of DDT. 
DDT and DNT were log-transformed to comply with test-assumptions. The presented estimates, 
Standard-Errors and 95% Confidence-Intervals (CI) (table 7+8) were back-transformed.  
 
To check for a learning-effect on DNT, DNT were tested with simple linear-regression as function 
of the consecutive patient-IDs to assess for systematic changes in DNT as consequence of gained 
experience among the stroke-team-members and institutional use of hyper-acute MRI.  
mRS at three months for CT versus MRI-allocated iv-PA-treated patients were compared with 
ANCOVA adjusted for the pre-onset mRS.  
Due to cases of cross-over between image-modalities, data are presented according to allocation 
(intention-to-treat) as well as according to the image-modality performed (per-protocol).  
Statistical analyses were conducted using SAS-Enterprise (Version 7.11, Cary, NC, USA) and IBM 
SPSS-Statistics (Version 20.0, IBM Corp, Armonk, NY, USA).   
The trail was approved by the Copenhagen-Regional-Ethics-Committee (H-4-2013-118) and the 
Danish Data-Protection-Agency (2007-58-0015) and registered at ClinicalTrials.gov 
(NCT02780843). 
Results: 
Four-hundred-forty-four consecutive patients presenting with symptoms of acute stroke within 
4.5 hours from symptoms-onset were included into this study (fig 1). Two-hundred-twenty-five 
patients were quasi-randomized for CT and 219 for MRI.  
Due to contraindications or when it was not possible to be sure about MRI-contraindications, 
cross-overs to CT-assessment were done in 52 (23.7%) MRI-allocated patients (table 1). In addition 
there was cross over for 40 (16.1%) MRI-allocated patients due to clinical conditions which 
required a CT-assessment and further 15 (6.8%) patients due to organizational issues. Twenty-two 
(9.8%) out of 225 CT-allocated patients received a MRI head scan: to avoid X-ray irradiation in a 
pregnant patient; 5 patients were <30 years; and further 16 patients had a doubtful clinical 
presentation of stroke which required MRI confirmation prior to receiving tPA.  
 
Baseline-characteristics according to allocation are presented in table 2 and according to actual 
image-modality conducted in table 3+4. 
Of the total number of patients presenting with symptoms of acute stroke, 140 (29.7%) were 
treated with iv-tPA of which 8 (5.7%) were later discharged with a stroke-mimic diagnosis.  
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Duration of CT and MRI-based evaluation:  
For iv-tPA-treated patients, the median DNT for CT-allocated patients was eight minutes shorter 
than for MRI-allocated patients (p=0.004) (table 5). For patients with ischemic stroke, both CT-
based DDT and DNT were significantly shorter; both according to allocation (p<0.005) and 
according to actual image-modality performed (p<0.002) (table 6+7).  
For patients with discharge-diagnosis of ICH, TIA or stroke-mimics, DDT was not significantly 
different for CT-based and MRI-based evaluation (table 5-7).  
The time from admission to image-initiation (Door-Scan-Time (DST)) was significantly shorter on 
CT-days for both Ischemic stroke and TIA-patients, both according to allocation and imaging 
conducted without cross-overs (table 5+6).  
No systematic time-dependent change in DNT were observed during the trial-period for CT 
(p=0.277) nor MRI (p=0.777)-based assessment. 
Predictors of DDT and DNT: 
Only MRI-allocation predicted DDT (table 8) and DNT (table 9) when allowed for the cluster-effect 
of the stroke-physicians and adjustment for; age, gender, stroke-severity, cross-over, stroke-
physician-seniority, the business of the shift and for DDT in addition for pre-onset-mRS, discharge-
diagnosis and additional image-sequences added to the SOP.   
 
Compared to MRI-allocated patients, the multilevel-models predicted a 24.0% shorter DDT 
(p=0.0001) and a 27% shorter DNT (p=0.008) for CT-allocated patients, table 8+9.  
 
Modified Rankin Scale at three month for iv-tPA-treated patients:  
Pre-mRS did not differ for CT (median 1.0 IQR 3.0) versus MRI-allocated (median 0.0 IQR 2.0) iv-
tPA-treated patients (p=0.096). 
When adjusted for pre-mRS, mRS at three month did not differ between CT (n=72, median 2.0 IQR 
2.0) and MRI (n=60, median 1.0 IQR 4.0) allocated iv-tPA-treated patients, p=0.275.  
 
Predicted long-term outcome for MRI-examined patients due to treatment-delay: 
When the paired predicted four outcomes were compared for each patient, only the chance of 
independent living differed between the two scenarios: Admission of a CT versus and MRI-day.  
The COMPASS-tool did not for any of the iv-tPA-treated MRI-allocated patients predict a change in 
the risk of SICH or death within three months as a consequence of the median 8 minutes longer 
MRI-allocated assessment.    
For elven (16.9%) of the 65 iv-tPA-treated MRI-allocated patients the predicted chance of 
independent living (mRS<3) at 3 months increased with 1% when the patient’s individual 
prediction were repeated with an 8 minutes shorter ONT; equaling the patients’ true individual 
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ONT subtracted the 8 minutes difference between the median DNT for CT and MRI-allocated 
patients (table 5). The difference in predicted chance of independent living if admitted on a CT 
versus an MRI-day did not exceed one percent for any of the 65 iv-tPA-treated MRI-allocated 
patients.  
 
Discussion: 
DNT were 8 minutes shorter for CT-allocated patients compared to MRI-allocated patients; a time-
difference that by simulated prediction decreased the chance of independent living at 3 months 
with 1% in 16.9% of the MRI-allocated iv-tPA-treated patients.   
 
MRI was not feasible in 23.7% of the MRI-allocated patients due to MRI-contra-indications and in 
additional 14.2% due to clinically conditions not compatible with safely conduction of MRI of 
diagnostic quality. In 9.8% of the CT-allocated patients MRI was conducted to avoid X-ray 
irradiation in pregnant or young patients or to establish the correct diagnosis prior to potential iv-
tPA administration.   
 
So far no previous randomized trial has compared DNT for CT versus MRI-allocated stroke-
patients. This quasi-randomized trial comparing CT versus MRI as first-line of brain-imaging in 
acute stroke patients was conducted in a stroke-unit conducting approximately 300 iv-tPA-
treatments each year. The iv-tPA-function is based on a well-organized set-up with guidelines for 
both evaluation and acute stroke-treatment.   
The study shows that MRI is a potential option in the acute stroke-setting— though significantly 
slower and less often feasible than CT. The study does not allow for assessment of the potential 
additional and clinically useful image-information gained when patients have MRI.  
The quasi-randomization allocated the patients into two well-balanced groups though males were 
more prevalent in the MRI-allocated group.  
The per-protocol-groups differed in both numbers and baseline-characteristics due to diverse 
clinical presentations, inherent MRI-contraindications and in some cases need of additional 
imaging.  
 
We wished to compare the use of CT and MRI in a clinical setting with patients reflecting patients 
with symptoms of acute stroke being brought to an acute stroke-unit for iv-tPA-assessment. 
Consequently no inclusion and exclusion-criteria were applied apart from a lower age limit and iv-
tPA-treatment-initiation within 4.5 hours from onset. Consequently the cohort includes patients 
with discharge-diagnosis of stroke, TIA as well as stroke-mimicking conditions.  
We did not observe a change in DNT for either CT or MRI-allocated patients throughout the trial-
period, indicating that a potential gained accumulative experience of the stroke-team did not 
influence the effectiveness of the patient-assessment.   
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Our MRI-protocol to rule out ICH prior to iv-tPA takes a total of 6.4 minutes compared to 17.3 
seconds for the non-contrast CT head. Shorter MRI-based protocols have been introduced (5) and 
could if used potentially have reduced the 8-minutes time-difference between CT and MRI-based 
evaluation. As previously reported (6), the interpretation of MRI-sequences can be initiated while 
the MRI is still underway contrary to how the CT-head must be completed before the image-
interpretation can be begun; consequently at least part of the treatment-delay caused by the 
longer MRI-protocol is reduced.   
 
Further MRI-safety is imperative and prolongs DNT in ways not inflicting CT-based evaluation; no 
time is devoted on ruling out MRI-contraindications or physical agitation affecting the diagnostic 
image-quality is less pronounced. Even instructions and positioning of the patient in the MRI-
scanner are usually more time-consuming compared to CT.  
In Helsinki (1), patients were transferred directly from the ambulance-stretcher to the CT-bed 
which is not feasible in a MRI-based acute setting as contraindications needs to be ruled out 
before the patient enters the MRI-room. To unify and thus be able to compare the CT and MRI-
based setup, all patients were received in the dedicated stroke-room on CT as well as MRI-days.  
Due to a limited number of patients, we were not allowed to test further predictors of DDT and 
DNT in our random-effect-models.  
We did not identify seniority of the stroke-physician as well as the work-intensity during the shift 
as predictors of DDT or DNT.  
As previously reported, nor gender or age of the patient (7, 8) or stroke-severity on admission (7) 
predicted DNT.  
 
As no patients were missed and DDT and DNT were registered for all patients, patient-bias does 
not influence the DNT-related results but for a total of 8 iv-tPA-treated patients it was not possible 
to obtain the three-month-follow-up mRS by telephone.  
Neither allocation-concealment nor blinding of patients and stroke-team-members were possible 
due to the clinical quasi-randomized setup and the nature of the CT and MRI-equipment.   
 
The allocation demonstrates a scenario of a hospital being either CT or MRI-based with MRI-
contraindications and clinical indications enforcing cross-overs from the primary chosen image-
modality. Deviations from the allocated imaging, on both CT and MRI-days potentially prolong 
DNT, though cross-overs were not identified as predictors of DDT or DNT in our random-effect-
model.  
Hundred-seven (48.9%) of the MRI-allocated patients and 22 (9.7%) of the CT-allocated patients 
had a cross-over to the non-allocated image-modality. Detection of a pacemaker, ferromagnetic 
implants or a body size too large to fit in the MRI-scanner are objective exclusion criteria, whereas 
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assessment of critically ill patients’ suitability for MRI is based on empirical experience and a 
situational evaluation of the individual patient. Unlike previous studies (17, 20, (9), we did not use 
immobilization of the patients’ heads or upper extremities or medical sedation to increase the 
number of MRI eligible patients otherwise too agitated for MRI of diagnostic quality. Nor did we 
use MRI-compatible monitoring of vital values or excluded patients with substantial functional 
deficits to increase the frequency of MRI-eligible patients (17, 20). Previous studies on selected 
acute stroke patients have reported MRI-contraindications in 3.1-12.4% of the examined patients 
(15, 17-19). Singer et al (10) further excluded acute stroke patients with reduced pre stroke 
functional status (mRS>1) who are more likely to have comorbidities resulting contraindications to 
MRI. Consequently our population included a higher number of patients with MRI-
contraindications (23.7%) compared to the previous reported studies.   
 
This single-center trial includes patients with mixed socioeconomic-status being admitted to an 
acute stroke-unit in a public Danish hospital; no private hospitals accept acute stroke-patients.  
We believe that our results generalizes what needs to be done in the acute setting; the patient-
history and blood-samples should be obtained, the physical examination performed and imaging 
conducted and interpreted to rule out ICH prior to iv-tPA-administration (1).   
The trial was conducted on weekdays during daytime and does thus not generalize to off-hours 
and weekends. 
 
Though the COMPASS-simulation-tool predicted that chance of independent living at 3 months 
decreased with 1% in 16.9% of the iv-tPA-treated MRI-allocated patients due to the median 
treatment-delay of 8 minutes compared to CT-allocated patients, it is important to stress that the 
inferior outcome in MRI-examined patients is based on predictions and not true established long-
term outcomes. Further did the mRS at three months indeed not differ between our iv-tPA-
treated CT versus MRI-allocated patients. The comparison was though based on a limited number 
of CT versus MRI-allocated patients and is likely not sufficiently powered. Long-term outcome has 
further previously been reported to be influenced by various patient-dependent factors (11-17).   
It is likely that a trial with a greater number of patients would be able to detect a difference in 
outcome between CT and MRI-allocated patients.   
 
To justify a potential time-related reduction in long-term outcome MRI must contribute with a 
higher diagnostic quality; in terms of a higher level of treatment-certainty or better still a lower 
frequency of iv-tPA-induced complications due to a more qualified selection of iv-tPA-candidates.  
As a large number of the patients were not able to have an acute MRI, use of MRI as first-line of 
brain-imaging is not uncomplicated. It is essential to have access to acute CT in case of patients 
with contraindications or patients unfit for MRI. Finally if MRI-based, one must consider the 
potentially treatment-delay in patients in need of CT instead of MRI.      
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Collaborating previous studies (1, 18), we had a low frequencies of iv-tPA treated patients with 
stroke-mimicking discharge-diagnosis in both the CT and the MRI-allocated groups; proving that 
fast and efficient assessment is attainable without compromising a high number of non-eligible 
patients.  
 
Conclusion: 
CT-based evaluation is significantly faster and more feasible than MRI-based assessment. In 
simulated prediction, the MRI-induced treatment-delay of 8 minutes potentially translates into a 
1% decreased chance of independent living (mRS<3) at 3 months in 16.9% of the iv-tPA-treated 
MRI-allocated patients— though not supported by the clinically reported mRS at three months.    
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Tables and figures: 
 
Fig 1. Flow chart of patients.  
Door-needle-time (DNT), Intravenous-tissue-Plasminogen-Activator (iv-tPA), modified-Rankin-Scale (mRS), 
Computer Tomography (CT) and Magnetic Resonance Imaging (MRI).  
 
 
 
 
 
444 Assessed for eligibility
444 Randomized 
225 Assigned to receive CT-assessment
203 Received CT-assessment
22 Recived MRI-assessment
75 iv-tPA-treated
DNT avaliable for all patients
3 patients 
mRS-follow-up not established by 
nurse
Subgroup analysis of 3-month 
follow-up:
72 included into analysis
3 excluded from analysis
150 not eligble for iv-tPA
219 Assigned to recive MRI-assessment
112 Received MRI-assessment
107 Recived CT-assessment
65 iv-tPA-treated
DNT avaliable for all patients
5 patients 
mRS-follow-up not established by 
nurse
Subgroup analysis of 3-month 
follow-up:
60 included into analysis
5 excluded from analysis
154 not eligble for iv-tPA
0 Excluded
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MRI-allocation  
(n=219) 
Received MRI 
(n=112) 
  
Cross-over to CT  
(n=107) 
Contraindications 
(n=52) 
Pacemaker (n=15) 
Ferromagnetic 
implants (n=5) 
Orbital metal splinters 
(n=1) 
Too large body size 
(n=8)  
Claustrophobia (n=6) 
Cervical hyperkyphosis 
(n=2) 
Explicit suspicion 
of MRI-
contraindications 
(n=15) 
Clinical condition 
(n=40) 
Critical medical 
condition (n=14) 
Physical unrest (n=17) 
Need for CT-
angiography including 
cervical vessel  (n=9) 
Organization  
(n=15)  
Waiting time for MRI> 
10 minutes (n=13) 
Close to iv-tPA-window 
(n=1) 
Simultaneous arrival of 
>1 patient (n=1) 
CT-allocation (N=225) Received CT (n=203)   
Cross-over to MRI (n=22) X-ray-related (n=6) Age<30 years of age 
(n=5) 
Pregnancy (n=1) 
Needed for diagnostic 
clarification (n=16) 
Clinical suspicion of 
space-occupying tumor 
(n=4) 
Diagnostic need for 
radiological signs of 
acute ischemia in 
patients with atypical 
clinical presentation 
(n=11)  
Suspicion of medullar 
compression (n=1) 
 
Table 1 Cross-overs from allocated image modality 
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 CT-allocated n= 225 MRI-allocated n= 219 p 
Age, years* 70 (26) 70 (24) 0.757 
Male gender 97 (44.1%) 118 (53.9%) 0.030 
NIHSS admission* 3 (7) 3 (6) 0.838 
mRS before onset* 1 (2) 1 (2) 0.743 
Thrombolysis 75 (33.3%) 65 (29.7%) 0.468 
Endovascular treatment 7 (3.1%) 6 (2.7%) 0.817 
Hypertension 91 (40.4%) 86 (39.3%) 0.876 
Hypercholesterolemia 56 (24.9%) 47 (22.4%) 0.457 
Atrial fibrillation 35 (15.6%) 40 (18.3%) 0.552 
Diabetes melitus 19 (8.4%) 26 (11.9%) 0.299 
Previous stroke/TIA 52 (23.1%) 54 (24.7%) 0.787 
Alcohol abuse 23 (10.2%) 21 (9.6%) 0.974 
Use of tobacco 47 (20.9%) 42 (19.2%) 0.777 
Discharge diagnosis    
Ischemic stroke 96 (43.6%) 89 (40.6%) 0.736 
TIA 40 (17.8%) 42 (19.2%) 0.797 
ICH 15 (6.7%) 22 (10.0%) 0.264 
Stroke-mimic 74 (32.9%) 66 (30.1%) 0.502 
Table 2, Baseline characteristics for CT and MRI-allocated patients, *median (IQR) 
 CT performed n= 310 MRI performed n= 134 p 
Age* 73.5 (22) 63.5 (29.25) 0.001 
Male gender 148 (47.7%) 67 (50%) 0.739 
NIHSS admission* 4 (10) 2 (5) 0.001 
mRS before onset* 1 (3) 0 (1) 0.001 
Thrombolysis 107 (34.5%) 33 (24.6%) 0.051 
Endovascular treatment 12 (3.9%) 1 (0.7) 0.059 
Hypertension 134 (43.2%) 43 (32.1%) 0.036 
Hypercholesterolemia 76 (24.5%) 27 (20.1%) 0.380 
Atrial fibrillation 56 (18.1%) 19 (14.2%) 0.387 
Diabetes melitus 36 (11.6%) 9 (6.7%) 0.162 
Previous stroke/TIA 77 (24.9%) 29 (21.6%) 0.546 
Alcohol abuse 32 (10.3%) 12 (9.0%) 0.798 
Use of tobacco 62 (20.0%) 77 (57.5%)  0.980 
Discharge diagnosis    
Ischemic stroke 140 (45.2%) 45 (33.6%) 0.030 
TIA 54 (17.4%) 28 (20.9%) 0.463 
ICH 29 (9.4%) 8 (6.0%) 0.319 
Stroke-mimic 87 (28.1%) 53 (39.6%) 0.023 
Table 3, Baseline Characteristics for CT and MRI-examined patients according to imaging performed (cross-
overed patients included), *median (IQR) 
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 CT-allocated n= 203 MRI-allocated n= 112 p 
Age* 71 (23) 67 (26.25) 0.001 
Male gender 92 (45.3%) 62 (55.4%) 0.112 
NIHSS admission* 3 (8) 2 (4) 0.006 
mRS before onset* 1 (2) 0 (1) 0.001 
Thrombolysis 73 (36.0%) 31 (27.7%) 0.170 
Hypertension 88 (18.8%) 40 (35.4%) 0.230 
Hypercholesterolemia 55 (27.1%) 26 (23.2%) 0.536 
Atrial fibrillation 33 (16.3%) 17 (15.0%) 0.929 
Diabetes melitus 19 (9.4%) 9 (8.0%) 0.851 
Previous stroke/TIA 48 (23.6%) 25 (22.3%) 0.899 
Alcohol abuse 23 (11.3%) 12 (10.7%) 0.889 
Use of tobacco 41 (36.6%) 21 (21.4%) 0.885 
Discharge diagnosis  
Ischemic stroke 94 (46.3%) 43 (38.4%) 0.316 
TIA 34 (16.7%) 22 (19.6%) 0.625 
ICH 15 (7.4%) 8 (7.1%) 0.936 
Stroke-mimic 60 (29.6%) 39 (34.8%) 0.403 
Table 4, Baseline Characteristics for CT and MRI-examined patients according to allocation (cross-overed 
patients excluded), *median (IQR) 
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  Onset-door-time Door-scan-time Door-decision-time Door-needle-time 
n Minutes* 
 
p Minutes* 
 
p Minutes* 
 
p n Minutes*  
 
p 
All patients CT 225 89  
(76) 
0.870 9 
(7) 
0.001 19  
(13) 
0.001  
MRI 219 87.0 
(75.0) 
12  
(9.0) 
23  
(15.0) 
Ischemic 
stroke  
CT 96 84.5  
(68) 
0.629 8  
(7.5) 
0.003 17  
(11) 
0.009 72 22  
(16) 
0.005 
MRI 89 80.5  
(77.8) 
10  
(10) 
23  
(13.0) 
60 30  
(14) 
ICH  CT 15 81  
(45) 
0.891 8  
(6.5) 
0.169 16  
(9) 
0.371  
MRI 22 75  
(53) 
13.5  
(11.75) 
18.5  
(12) 
TIA  CT 40 102  
(86) 
0.937 9  
(5.25) 
0.002 20  
(14.5) 
0.089  
MRI 42 97  
(91.5) 
13.5  
(9) 
25  
(17) 
Stroke-
mimics 
CT 74 92.5 
(93.25) 
0.859 11  
(12.5) 
0.329 19  
(10.75) 
0.169 3 25 0.571 
MRI 66 107.5 
(89.5) 
11  
(9.25) 
23.5  
(17.5) 
5 41  
(36) 
All iv-tpA-
treated 
patients 
CT 75 84.5  
(72) 
0.136 8  
(6) 
0.001 16.5  
(10) 
0.001 75 22   
(15.5) 
0.004 
MRI 65 71  
(74) 
9.75  
(9.75) 
23  
(12.0) 
65 30.0  
(14.0) 
Table 5, Time intervals for patients according allocation and discharge diagnosis. *Minutes, median (IQR) 
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  Onset-door-
time 
Door-scan-time Door-decision-
time 
Door-needle-time 
n Minute
s* 
 
p Minutes* 
 
p Minutes* 
 
p n Minutes*  
 
p 
All patients CT 203 89.0  
(77.5) 
0.940 8.5  
(8) 
0.001 18  
(12.5) 
0.001  
MRI 112 92  
(81.5) 
12.5  
(11) 
26  
(15) 
Ischemic 
stroke  
CT 94 88  
(71.5) 
0.620 8  
(7.5) 
0.038 17  
(11) 
0.001 70 22  
(15.5) 
0.001 
MRI 43 94  
(82) 
10  
(10.5) 
26  
(13.5) 
30 32  
(12.5) 
ICH  CT 15 81  
(45) 
0.428 8  
(6.5) 
0.053 16  
(14) 
0.089  
MRI 8 70.5  
(44.3) 
16  
(6.8) 
25.5  
(13.8) 
TIA  CT 43 90  
(85.5) 
0.918 8.5  
(4.8) 
0.002 20  
(14) 
0.077  
MRI 22 89 
(84.3) 
14.5  
(9.5) 
25  
(17) 
Stroke-
mimics 
CT 60 100 
(83.8) 
0.823 10  
(12) 
0.226 19  
(12) 
0.139 3 25 0.500 
MRI 39 100.2 
(95.5) 
12  
(9.8) 
27  
(20) 
1 51 
tpA-treated 
patients 
CT 73 88  
(72.8) 
0.420 8  
(6) 
0.006 
 
16  
(10) 
0.001 73 22  
(15) 
0.001 
MRI 31 84.5  
(84.3) 
11  
(9) 
25  
(13.5) 
31 34  
(14) 
Table 6; Time intervals for patients according to allocation, cross-overed patients excluded. * Minutes, 
median (IQR) 
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  Onset-door-time Door-scan-time Door-decision-
time 
Door-needle-time 
N Minutes* 
 
p Minutes* 
 
p Minutes* 
 
p n Minutes*  
 
p 
All patients CT 310 88.0  
(71.0) 
0.929 10  
(7.5) 
0.001 19  
(12) 
0.001  
MRI 134 89.5  
(79.8) 
12  
(10.3) 
25 
(15) 
Ischemic 
stroke  
CT 140 80.0 
(67.0) 
0.557 9 
(7.5) 
0.175 18  
(11.25) 
0.001 100 23 
(17.0) 
0.002 
MRI 45 82  
(85) 
10 
(9.8) 
26 
(13.8) 
32 32 
(14) 
ICH  CT 29 82.5 
(56.5) 
0.307 10 
(8) 
0.061 16 
(8) 
0.05  
MRI 8 70.5 
(44.3) 
16 
(6.8) 
25.5 
(13.8) 
TIA  CT 54 100 
(88.5) 
0.982 10 
(6.8) 
0.009 21 
(14) 
0.170  
MRI 28 102 
(88.5) 
13 
(9) 
25.5 
(17.3) 
Stroke-
mimics 
CT 87 103.5 
(80.5) 
0.476 11 
(10) 
0.177 20 
(12) 
0.196 7 25  
(27) 
0.250 
MRI 53 84.5 
(93.3) 
12  
(10) 
22.5 
(17) 
 
1 51 
tpA-treated 
patients 
CT 107 80 
(67.5) 
0.511 9 
(7) 
0.036 17 
(12) 
0.001 107 23.0 
(16.5) 
0.001 
MRI 33 78 
(84.5) 
11 
(9) 
26 
(13.8) 
33 34 
(14) 
Table 7, Time intervals for patients according to imaging conducted, cross-overs included. *Minutes, 
median (IQR) 
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Table 8 Random effect multilevel model identifying predictors of “door-decision-times”  and allowing the 
cluster effect of the 24 stroke physicians. The dependent variable door-to-decision-time was log10-
transformed to comply with test assumptions; estimates, Standard Errors and CI have been 
backtransformed. 
*  Versus MRI-allocation, **versus Late neurological  resident, *** versus stroke mimic discharge diagnosis 
 Estimate Standard Error 95% CI  Significance 
Intercept 21.677 1.166 16.018-
29.336 
0.0001 
Age 0.999 1.001 0.997-1.002 0.763 
Female gender 1.087 1.054 0.980-1.208 0.115 
NIHSS on 
admission 
0.998 1.005 0.989-1.008 0.749 
mRS prior onset 1.009 1.022 0.967-1.052 0.685 
CT allocation* 0.760 1.068 0.668-0.864 0.0001 
Cross-over to CT 
for MRI-allocated 
patients 
1.097 1.067 0.964-1.246 0.153 
Cross-over to 
MRI for CT-
allocated 
patients 
0.952 1.139 0.737-1.29 0.703 
Neurological 
consultant**  
 
1.117 1.091 0.914-1.366 0.241 
Senior stroke 
neurological 
consultant** 
1.165 1.091 0.913-1.268 0.093 
Ischemic 
stroke*** 
1.076 1.087 0.913-1.144 0.378 
Transitory 
Ischemic 
Attack***  
1.150 1.082 0.985-1.343 0.077 
Intracranial 
Hemorrhage***  
0.913 1.122 0.729-1.144 0.429 
No tPA-
prescribed  
1.080 1.085 0.920-1.269 0.346 
Minutes to 
arrival of next 
patient, intervals 
of 20 minutes 
0.987 1.007 0.973-1.001 0.077 
Number of 
patients 
evaluated during 
shift 
0.993 1.024 0.948-1.041 0.7769 
Additional 
imaging 
performed 
1.097 1.075 0.952-1.264 0.200 
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 Estimate Standard 
Error 
95% CI  Significance 
Intercept 37.350 1.350 20.587-
67.764 
0.0001 
Age 1.002 1.003 0.995-
1.008 
0.627 
Female gender 1.189 1.096 0.991-
1.426 
0.063 
NIHSS on 
admission 
0.985 1.008 0.971-
1.000 
0.054 
CT-allocation* 0.730 1.123 0.5580-
0.920 
0.008 
Cross-over to 
CT for MRI-
allocated 
patients 
1.457 1.127 0.912-
1.468 
0.226 
Cross-over to 
MRI for CT-
allocated 
patient 
1.111 1.416 0.557-
2.215 
0.763 
Neurological 
consultant* * 
 
0.986 1.183 0.699-
1.391 0.935 
Senior stroke 
neurological 
consultant **  
1.077 1.221 0.971-
1.605 0.054 
Minutes to 
arrival of next 
patient, 
intervals of 10 
minutes 
0.980 1.013 0.956-
1.005 
0.123 
Number of 
patients 
evaluated 
during shift 
0.945 1.047 0.863-
1.035 
0.219 
Table 9 Random effect multilevel model identifying predictors of “door-needle-times” and allowing the 
cluster effect of the 24 stroke physicians. The dependent variable door-to-decision-time was log10-
transformed to comply with test assumptions; estimates, Standard Errors and CI have been back-
transformed. 
 
*versus MRI-allocation performed, **versus Late neurological resident  
 
